Sharon Thurow
Nurse Practitioner · Thiensville, WINPI 1215044326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 388 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 388 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$856
- Astellas Pharma US Inc$693
- Amgen$480
- AstraZeneca$454
- Novo Nordisk$393
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,84495%
- Education$3405%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 87 | $1,156 |
| Lilly USA, LLC | 67 | $856 |
| Astellas Pharma US Inc | 25 | $693 |
| Amgen(2 entities) | 31 | $480 |
| AstraZeneca(2 entities) | 26 | $454 |
| Novo Nordisk | 27 | $393 |
| Collegium Pharmaceutical, Inc. | 21 | $366 |
| Pfizer | 21 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $295 |
| Exact Sciences | 8 | $178 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $98 |
| Esperion Therapeutics, Inc. | 5 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $85 |
| Boehringer Ingelheim | 4 | $67 |
| Biohaven Pharmaceuticals, Inc. | 4 | $60 |
| Merck | 3 | $49 |
| Amarin Pharma, Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Biodelivery Sciences International, Inc. | 3 | $37 |
| Corium, LLC | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Abbott | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
How this compares
$6,184 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 23 | $19,161 |
| RybelsusSemaglutide | 16 | $17,565 |
| JanuviaSitagliptin Phosphate | 14 | $15,852 |
| VeozahFezolinetant | 13 | $15,421 |
| VascepaIcosapent Ethyl | 17 | $11,230 |
| TradjentaLinagliptin | 19 | $8,539 |
| Omega-3 Acid Ethyl Esters | 51 | $6,270 |
| Armour ThyroidThyroid,pork | 20 | $2,595 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $1,697 |
| Nebivolol Hcl | 23 | $1,570 |
| Liothyronine Sodium | 33 | $1,508 |
| Ezetimibe | 72 | $1,142 |
| Rosuvastatin Calcium | 65 | $882 |
| Levothyroxine Sodium | 77 | $859 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $788 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra, Januvia | $49 | $35,01337 claims |
| Novo NordiskRybelsus | $393 | $17,56516 claims |
| Astellas Pharma US IncVeozah | $693 | $15,42113 claims |
| Boehringer IngelheimTradjenta | $67 | $8,53919 claims |
| AbbVieArmour Thyroid | $1,156 | $2,59520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in Thiensville
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
- Kari FisherPrairie du Sac$57K
- Roxanne RadichAppleton$54K
- Kelly FlugaurMilwaukee$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.